Heart Failure Research

Heart failure, also known as congestive heart failure or CHF, is an inability of the heart to pump sufficient blood around the body.Heart failure typically occurs secondary to an existing pathology that alters cardiac function. Examples of syndromes that can precede heart failure include myocardial infarction, arrhythmia or infection. These can also cause dilated cardiomyopathy, a condition which accounts for approximately one third of all cases of heart failure. The pathogenesis of heart failure is cyclical and progressive; endogenous mechanisms, which are activated during heart failure in an attempt to counteract the symptoms, actually worsen cardiac function. Cardiac dysfunction, either systolic or diastolic, triggers a decrease in stroke volume and a resultant increase in cardiac output. In healthy individuals the body responds to decreases in cardiac output by initiating the renin-angiotensin-aldosterone system (RAAS) to promote fluid retention, and also by activating the sympathetic nervous system to cause peripheral vasoconstriction. Under normal circumstances this counteracts the imbalance in stroke volume, restoring cardiac output to normal levels. In patients with heart failure the increase in blood volume, together with the heightened peripheral resistance and elevated levels of circulating catecholamines, causes an increased load on the already weakened ventricles with each contraction, and the stroke volume does not return to normal levels. Repeated cycles of this process further weaken the ventricle walls, prompting ventricular hypertrophy and a decreased force of contraction.

Heart Failure Research Products Targets

Products for Heart Failure Research - Page 14

  1. Cat.No. Product Name Information/Activity
  2. BCC5644 Pentamidine isethionate Pentamidine isethionate (MP-601205 isethionate) is an antimicrobial agent and interferes with DNA biosynthetics. Pentamidine isethionate inhibits parasite Leishmania infantum with an IC50 of 2.5 μM. Pentamidine isethionate is a potent and selective protein tyrosine phosphatases (PTPases) and phosphatase of regenerating liver (PRL) inhibitor. Pentamidine isethionate has the potential for Gambian trypanosomiasis, antimony-resistant leishmaniasis, and Pneumocystis carinii pneumonia treatment. Antitumor and antibacterial activities. Pentamidine isethionate chemical structure
  3. BCC6965 Nω-Propyl-L-arginine hydrochloride 137361-05-8 Nω-Propyl-L-arginine hydrochloride chemical structure
  4. BCC6762 N-Acetyl-N-acetoxy-4-chlorobenzenesulfonamide 142867-52-5 N-Acetyl-N-acetoxy-4-chlorobenzenesulfonamide chemical structure
  5. BCN2691 L-Arginine L-Arginine is the nitrogen donor for synthesis of nitric oxide, a potent vasodilator that is deficient during times of sickle cell crisis. L-Arginine chemical structure
  6. BCC7944 NCX 4040 287118-97-2 NCX 4040 chemical structure
  7. BCC6219 NCX 466 1262956-64-8 NCX 466 chemical structure
  8. BCC5004 Nicorandil Nicorandil (SG-75) is potassium channel activator. Nicorandil chemical structure
  9. BCC5670 SIN-1 chloride 16142-27-1 SIN-1 chloride chemical structure
  10. BCC6712 SNAP 79032-48-7 SNAP chemical structure
  11. BCC6714 SNOG 57564-91-7 SNOG chemical structure

Items 131 to 140 of 148 total